Full text
Earnings transcript
Read the complete earnings call transcript.
EG
Everest Group, Ltd.
$375.6
-4.18
(-1.1%)
| Exchange: | NYSE |
| Market Cap: | 14.863B |
| Shares Outstanding: | 50.8M |
Delayed data
About The Company
| Sector: | Financial Services | |||||
| Industry: | Insurance – Reinsurance | |||||
| CEO: | James Williamson | |||||
| Full Time Employees: | 3064 | |||||
| Address: |
| |||||
| Website: | https://www.everestglobal.com |
Everest Group, Ltd., together with subsidiaries, provides reinsurance and insurance products in the United States, Europe, and internationally. It operates in two segment, Insurance and Reinsurance. The company writes property and casualty reinsurance; treaty and facultative reinsurance products; and specialty lines of business through reinsurance brokers, as well as directly with ceding companies; and writes property and casualty insurance directly, as well as through brokers, surplus lines, and general agents. It provides reinsurance products comprising mortgage, catastrophe, marine, aviation, engineering, professional line, credit and surety, motor, agriculture/crop, and political violence reinsurance products. In addition, the company offers commercial property and casualty insurance products through wholesale and retail brokers, surplus lines brokers, and program administrators. The company was formerly known as Everest Re Group, Ltd. and changed its name to Everest Group, Ltd. in July 2023.Everest Group, Ltd., was founded in 1973 and is headquartered in Hamilton, Bermuda.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 14,464,000 | 17,076,000 | 17,318,000 |
| Gross Profit | 3,085,000 | 2,471,000 | 3,553,700 |
| EBITDA | 2,288,000 | 1,642,000 | 2,068,000 |
| Operating Income | 2,154,000 | 1,495,000 | 1,954,000 |
| Net Income | 2,517,000 | 1,373,000 | 1,591,000 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 49,399,000 | 56,341,000 | 62,514,000 |
| Total Liabilities | 36,197,000 | 42,465,000 | 47,054,000 |
| Total Stockholders Equity | 13,202,000 | 13,876,000 | 15,460,000 |
| Total Debt | 5,735,000 | 5,937,000 | 3,589,000 |
| Cash and Cash Equivalents | 1,437,000 | 1,549,000 | 1,318,000 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 4,553,000 | 4,957,000 | 3,068,000 |
| Capital Expenditure | 0 | 0 | 0 |
| Free Cash Flow | 4,553,000 | 4,957,000 | 3,068,000 |
| Net Income | 2,517,000 | 1,373,000 | 1,591,000 |
| Net Change in Cash | 39,000 | 112,000 | -231,000 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2028 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 13,414,457.166 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 15,440,309.127 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 14,506,758.633 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 1,539,715.185 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 1,772,243.046 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 1,665,089.856 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 2,681,843.153 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 2,886,966.298 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 2,784,404.726 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 195,128.651 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 224,596.989 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 211,017.428 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 67.880 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 69.710 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 64.760 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 6 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 3 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Strong Financial Performance in Q2 2025: As highlighted in the latest earnings call transcript, Everest Group reported robust financial results for Q2 2025, with net income and revenue exceeding expectations. This reflects operational efficiency and effective cost management, positioning the company favorably within the insurance and reinsurance markets.
- Positive Industry Positioning: Performance metrics indicate that EG has outperformed its industry peers over multiple time frames (1-week, 1-month, and 3-month periods), supported by sector and industry performance data. This suggests a competitive edge within the insurance sector.
- Healthy Profitability Metrics: Key metrics such as gross profit margin TTM and net profit margin TTM demonstrate strong profitability compared to industry averages, underpinned by consistent revenue growth as seen in income statements over recent years.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates EG intrinsic value between $705.68 – $1,712.18 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about EG valuation
Is Everest Group, Ltd. (EG) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Everest Group, Ltd. (EG) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is EG a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether EG trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is EG’s P/E ratio?
You can see EG’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for EG?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is EG a good long-term investment?
Whether EG fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
EG
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-1.1
Trading Metrics:
| Open: | 377.05 | Previous Close: | 379.78 | |
| Day Low: | 372.63 | Day High: | 379.91 | |
| Year Low: | 302.44 | Year High: | 401.07 | |
| Price Avg 50: | 367.99 | Price Avg 200: | 340.95 | |
| Volume: | 83891 | Average Volume: | 376761 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeEG full analysis
Welcome to MARKETSNAP’s SWOT analysis for Everest Group Limited, also known by its ticker EG. If you’re a long-term investor looking to dive deep into the potential of this player in the insurance and reinsurance space, you’re in the right place. Today, we’re breaking down the strengths, weaknesses, opportunities, and threats for Everest Group, giving you a clear picture of whether this stock deserves a spot in your portfolio. Let’s get started with a quick overview of who they are…
